EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Spotlight on the Mechanism of Action of Semaglutide

Ilias Papakonstantinou iD, Konstantinos Tsioufis iD, Vasiliki Katsi

Current Issues in Molecular Biology · 23.12.2024 · 46 (12) · 14514-14541

DOI: 10.3390/cimb46120872 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 23.12.2024. Verfasst von Ilias Papakonstantinou und 2 weiteren Autor:innen. Beteiligte Einrichtung: 4th Department of Internal Medicine, Evangelismos General Hospital, 10676 Athens, Greece. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Initially intended to control blood glucose levels in patients with type 2 diabetes, semaglutide, a potent glucagon-like peptide 1 analogue, has been established as an effective weight loss treatment by controlling appetite. Integrating the latest clinical trials, semaglutide in patients with or without diabetes presents significant therapeutic efficacy in ameliorating cardiometabolic risk factors and physical functioning, independent of body weight reduction. Semaglutide may modulate adipose tissue browning, which enhances human metabolism and exhibits possible benefits in skeletal muscle degeneration, accelerated by obesity and ageing. This may be attributed to anti-inflammatory, mitochondrial biogenesis, antioxidant and autophagy-regulating effects. However, most of the supporting evidence on the mechanistic actions of semaglutide is preclinical, demonstrated in rodents and not actually confirmed in humans, therefore warranting caution in the interpretation. This article aims to explore potential innovative molecular mechanisms of semaglutide action in restoring the balance of several interlinking aspects of metabolism, pointing to distinct functions in inflammation and oxidative stress in insulin-sensitive musculoskeletal and adipose tissues. Moreover, possible applications in protection from infections and anti-aging properties are discussed. Semaglutide enhancement of the core molecular mechanisms involved in the progress of obesity and diabetes, although mostly preclinical, may provide a framework for future research applications in human diseases overall.

Schlagwörter

Stichwörter der Autor:innen

adiposeagingautophagybrowningdiabetesinfectionsinflammationobesitysarcopeniasemaglutide

Autor:innen und Institutionen

  • 4th Department of Internal Medicine, Evangelismos General Hospital, 10676 Athens, Greece.
  • 1st Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece.

ORCID-Profile: Ilias Papakonstantinou, Konstantinos Tsioufis

Zitieren

APA

Papakonstantinou, I., Tsioufis, K., & Katsi, V. (2024). Spotlight on the Mechanism of Action of Semaglutide. Current Issues in Molecular Biology, 46(12), 14514-14541. https://doi.org/10.3390/cimb46120872

Vancouver

Papakonstantinou I, Tsioufis K, Katsi V. Spotlight on the Mechanism of Action of Semaglutide. Current Issues in Molecular Biology. 2024;46(12):14514-14541. doi:10.3390/cimb46120872

BibTeX
@article{Papakonstantinou2024,
  author = {Papakonstantinou, Ilias and Tsioufis, Konstantinos and Katsi, Vasiliki},
  title = {Spotlight on the Mechanism of Action of Semaglutide},
  journal = {Current Issues in Molecular Biology},
  year = {2024},
  volume = {46},
  number = {12},
  pages = {14514--14541},
  doi = {10.3390/cimb46120872}
}
Kostenlos starten →